HomeLSL • CVE
add
LSL Pharma Group Inc
Previous close
$0.40
Day range
$0.38 - $0.39
Year range
$0.29 - $0.50
Market cap
43.32M CAD
Avg Volume
43.69K
P/E ratio
12.85
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 5.38M | 55.68% |
Operating expense | 1.26M | 37.12% |
Net income | 4.50M | 454.25% |
Net profit margin | 83.55 | 327.53% |
Earnings per share | — | — |
EBITDA | 481.00K | 160.35% |
Effective tax rate | 1.10% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 296.00K | 3,600.00% |
Total assets | 53.51M | 73.17% |
Total liabilities | 28.62M | 28.65% |
Total equity | 24.89M | — |
Shares outstanding | 115.53M | — |
Price to book | 1.82 | — |
Return on assets | 1.18% | — |
Return on capital | 1.33% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 4.50M | 454.25% |
Cash from operations | 452.00K | 3,376.92% |
Cash from investing | -2.14M | -393.53% |
Cash from financing | 1.82M | 296.72% |
Net change in cash | 132.00K | 247.37% |
Free cash flow | -2.98M | -30.11% |
About
Founded
2010
Website
Employees
186
